Eleonora Salles-Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eleonora Salles-Silva has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Daniella Braz Parente
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
5 shared publications - Antonio Luis Eiras-Araujo
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
3 shared publications - Rosana Souza Rodrigues
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
3 shared publications - André Barboza Ferreira
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
2 shared publications - Luana Lemos Alves
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
2 shared publications - Miriam Menna Barreto
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
2 shared publications
Latest Publications
- Open Access
- 22 June 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (12) , 6218-6238
Beyond morphology: functional imaging of the liver with gadoxetic acid-enhanced magnetic resonance imaging
Chronic liver diseases (CLD) are highly prevalent. Early diagnosis and staging of hepatic dysfunction are essential for optimal treatment decisions. While conventional imaging primarily evaluates morphology and focal liver lesions, gadoxetic acid (GA)-enhanced magnetic resonance imaging (MRI) provides additional functional information by assessing hepatocellular uptake and biliary excretion. Hepatocyte uptake depends largely on sinusoidal membrane transporters (OATP1B1/1B3), while excretion into bile canaliculi is mediated by MRP2. In liver dysfunction and cirrhosis, both processes may be impaired, resulting in measurable changes on hepatobiliary phase (HBP). This review summarizes the biological rationale, MRI protocol, and quantitative indices, including RLE, REI, HUI, rHUI, SIR, CUI, LSI, as well as the qualitative Functional Liver Imaging Score (FLIS). It also highlights key clinical applications, including prognostication in advanced CLD, preoperative risk stratification for post-hepatectomy liver failure, evaluation in the setting of embolization and locoregional therapies, and transplant assessment, along with emerging roles in metabolic dysfunction-associated steatotic liver disease. Finally, future directions are discussed, including T1 mapping and AI-based whole-liver quantification.
- 22 June 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (12) , 6218-6238
Open AccessBeyond morphology: functional imaging of the liver with gadoxetic acid-enhanced magnetic resonance imaging
Chronic liver diseases (CLD) are highly prevalent. Early diagnosis and staging of hepatic dysfunction are essential for optimal treatment decisions. While conventional imaging primarily evaluates morphology and focal liver lesions, gadoxetic acid (GA)-enhanced magnetic resonance imaging (MRI) provides additional functional information by assessing hepatocellular uptake and biliary excretion. Hepatocyte uptake depends largely on sinusoidal membrane transporters (OATP1B1/1B3), while excretion into bile canaliculi is mediated by MRP2. In liver dysfunction and cirrhosis, both processes may be impaired, resulting in measurable changes on hepatobiliary phase (HBP). This review summarizes the biological rationale, MRI protocol, and quantitative indices, including RLE, REI, HUI, rHUI, SIR, CUI, LSI, as well as the qualitative Functional Liver Imaging Score (FLIS). It also highlights key clinical applications, including prognostication in advanced CLD, preoperative risk stratification for post-hepatectomy liver failure, evaluation in the setting of embolization and locoregional therapies, and transplant assessment, along with emerging roles in metabolic dysfunction-associated steatotic liver disease. Finally, future directions are discussed, including T1 mapping and AI-based whole-liver quantification.
- Open Access
- 10 February 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (8) , 1-13
Multimodal imaging features to diagnose abdominal complications of sickle cell disease
Sickle cell disease (SCD) is a hereditary hemoglobinopathy, marked by chronic hemolysis and recurrent vaso-occlusive crises, which frequently leads to a wide range of abdominal complications. Sickled erythrocytes have reduced deformability and increased adhesion to vessel walls, leading to chronic vascular occlusion, inflammation, and hemolysis. Comprehensive imaging plays a pivotal role in the early detection and assessment of these complications, thereby mitigating morbidity and severe outcomes. Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) are the three modalities commonly used on SCD patients to evaluate hepatosplenic involvement, renal pathology, pancreatobiliary disorders, gastrointestinal ischemia, extramedullary hematopoiesis, and genital abnormalities. The US is a first-line imaging tool due to its accessibility and low cost. CT offers high-resolution, cross-sectional imaging and is often utilized in emergency settings. MRI, with its superior soft tissue contrast, is excellent for problem-solving. A thorough understanding of the abdominal manifestations of SCD is essential for radiologists to provide accurate diagnoses, guide clinical decision-making, and reduce morbidity and mortality. This review highlights the most significant imaging findings from SCD abdominal complications, emphasizing their clinical implications, underlying pathophysiology, and radiological features in all three modalities.
- 10 February 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (8) , 1-13
Open AccessMultimodal imaging features to diagnose abdominal complications of sickle cell disease
Sickle cell disease (SCD) is a hereditary hemoglobinopathy, marked by chronic hemolysis and recurrent vaso-occlusive crises, which frequently leads to a wide range of abdominal complications. Sickled erythrocytes have reduced deformability and increased adhesion to vessel walls, leading to chronic vascular occlusion, inflammation, and hemolysis. Comprehensive imaging plays a pivotal role in the early detection and assessment of these complications, thereby mitigating morbidity and severe outcomes. Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) are the three modalities commonly used on SCD patients to evaluate hepatosplenic involvement, renal pathology, pancreatobiliary disorders, gastrointestinal ischemia, extramedullary hematopoiesis, and genital abnormalities. The US is a first-line imaging tool due to its accessibility and low cost. CT offers high-resolution, cross-sectional imaging and is often utilized in emergency settings. MRI, with its superior soft tissue contrast, is excellent for problem-solving. A thorough understanding of the abdominal manifestations of SCD is essential for radiologists to provide accurate diagnoses, guide clinical decision-making, and reduce morbidity and mortality. This review highlights the most significant imaging findings from SCD abdominal complications, emphasizing their clinical implications, underlying pathophysiology, and radiological features in all three modalities.
- 30 June 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (2) , 1004-1015
Multimodal imaging features to diagnose abdominal complications of sickle cell disease
Sickle cell disease (SCD) is a hereditary hemoglobinopathy, marked by chronic hemolysis and recurrent vaso-occlusive crises, which frequently leads to a wide range of abdominal complications. Sickled erythrocytes have reduced deformability and increased adhesion to vessel walls, leading to chronic vascular occlusion, inflammation, and hemolysis. Comprehensive imaging plays a pivotal role in the early detection and assessment of these complications, thereby mitigating morbidity and severe outcomes. Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) are the three modalities commonly used on SCD patients to evaluate hepatosplenic involvement, renal pathology, pancreatobiliary disorders, gastrointestinal ischemia, extramedullary hematopoiesis, and genital abnormalities. The US is a first-line imaging tool due to its accessibility and low cost. CT offers high-resolution, cross-sectional imaging and is often utilized in emergency settings. MRI, with its superior soft tissue contrast, is excellent for problem-solving. A thorough understanding of the abdominal manifestations of SCD is essential for radiologists to provide accurate diagnoses, guide clinical decision-making, and reduce morbidity and mortality. This review highlights the most significant imaging findings from SCD abdominal complications, emphasizing their clinical implications, underlying pathophysiology, and radiological features in all three modalities.
- 30 June 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (2) , 1004-1015
Multimodal imaging features to diagnose abdominal complications of sickle cell disease
Sickle cell disease (SCD) is a hereditary hemoglobinopathy, marked by chronic hemolysis and recurrent vaso-occlusive crises, which frequently leads to a wide range of abdominal complications. Sickled erythrocytes have reduced deformability and increased adhesion to vessel walls, leading to chronic vascular occlusion, inflammation, and hemolysis. Comprehensive imaging plays a pivotal role in the early detection and assessment of these complications, thereby mitigating morbidity and severe outcomes. Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) are the three modalities commonly used on SCD patients to evaluate hepatosplenic involvement, renal pathology, pancreatobiliary disorders, gastrointestinal ischemia, extramedullary hematopoiesis, and genital abnormalities. The US is a first-line imaging tool due to its accessibility and low cost. CT offers high-resolution, cross-sectional imaging and is often utilized in emergency settings. MRI, with its superior soft tissue contrast, is excellent for problem-solving. A thorough understanding of the abdominal manifestations of SCD is essential for radiologists to provide accurate diagnoses, guide clinical decision-making, and reduce morbidity and mortality. This review highlights the most significant imaging findings from SCD abdominal complications, emphasizing their clinical implications, underlying pathophysiology, and radiological features in all three modalities.
- 20 June 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (12) , 4494-4506
Clear cell likelihood score may improve diagnosis and management of renal masses
The detection of solid renal masses has increased over time due to incidental findings during imaging studies conducted for unrelated medical conditions. Approximately 20% of lesions measuring less than 4 cm are benign and 80% are malignant. Clear cell renal cell carcinoma (ccRCC) is the most frequent among renal carcinomas, responsible for 65–80% of cases. The increased detection of renal masses facilitates early diagnosis and treatment. However, it also leads to more invasive interventions, which result in higher morbidity and costs. Currently, only histological analysis can offer an accurate diagnosis. Surgical nephron loss significantly elevates morbidity and mortality rates. Active surveillance represents a conservative management approach for patients diagnosed with a solid renal mass that is endorsed by both American Urological Association and the European Society for Medical Oncology. However, active surveillance is used in a minority of patients and varies across institutions. The lack of clinical studies using a standardized approach to incidentally detected small renal masses precludes the widespread use of active surveillance. Hence, there is an urgent need for better patient selection, distinguishing those who require surgery from those suitable for active surveillance. The clear cell likelihood score (ccLS) represents a novel MRI tool for assessing the probability of a renal mass being a ccRCC. In this study, we present a comprehensive review of renal masses and their evaluation using the ccLS to facilitate shared decision between urologists and patients. Graphical Abstract
- 20 June 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (12) , 4494-4506
Clear cell likelihood score may improve diagnosis and management of renal masses
The detection of solid renal masses has increased over time due to incidental findings during imaging studies conducted for unrelated medical conditions. Approximately 20% of lesions measuring less than 4 cm are benign and 80% are malignant. Clear cell renal cell carcinoma (ccRCC) is the most frequent among renal carcinomas, responsible for 65–80% of cases. The increased detection of renal masses facilitates early diagnosis and treatment. However, it also leads to more invasive interventions, which result in higher morbidity and costs. Currently, only histological analysis can offer an accurate diagnosis. Surgical nephron loss significantly elevates morbidity and mortality rates. Active surveillance represents a conservative management approach for patients diagnosed with a solid renal mass that is endorsed by both American Urological Association and the European Society for Medical Oncology. However, active surveillance is used in a minority of patients and varies across institutions. The lack of clinical studies using a standardized approach to incidentally detected small renal masses precludes the widespread use of active surveillance. Hence, there is an urgent need for better patient selection, distinguishing those who require surgery from those suitable for active surveillance. The clear cell likelihood score (ccLS) represents a novel MRI tool for assessing the probability of a renal mass being a ccRCC. In this study, we present a comprehensive review of renal masses and their evaluation using the ccLS to facilitate shared decision between urologists and patients. Graphical Abstract